Ziagen Indications/Uses





Agencia Lei Va Hong
Full Prescribing Info
Ziagen is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults, adolescents and children (see Precautions and Pharmacology: Pharmacodynamics under Actions).
The demonstration of the benefit of Ziagen is mainly based on results of studies performed in treatment-naïve adult patients on combination therapy with a twice daily regimen (see Pharmacology: Pharmacodynamics: Clinical efficacy and safety: Twice daily (300 mg) administration: Therapy naïve adults under Actions).
Before initiating treatment with abacavir, screening for carriage of the HLA-B*5701 allele should be performed in any HIV-infected patient, irrespective of racial origin (see Hypersensitivity reaction under Warnings). Abacavir should not be used in patients known to carry the HLA-B*5701 allele.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in